The PI3K-Akt pathway is over-expressed or activated in chemoresistant ovarian cancer cells and Akt down-regulation sensitizes chemoresistant wt-p53 cells to CDDP-induced apoptosis [2,11]. This evidence concerns the gene TP53 and ovarian carcinoma.